HomeInsightsMarket Capitalization

Market Capitalization of Panacea Biotec Ltd

Market Capitalization of Panacea Biotec Ltd

stocks purchased

₹ 1.4 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

30.7 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Panacea Biotec Ltd

NSE: PANACEABIO

Market Cap

₹ 2768.84 crore

Last updated on: Dec 26, 2024

Key Highlights

  • The Market Cap of Panacea Biotec Ltd is ₹ 2768 crore as of 26 Dec 24 .
  • The Market Cap of Panacea Biotec Ltd changed from ₹ 1213 crore on March 2019 to ₹ 742.97 crore on March 2024 . This represents a CAGR of -7.86% over 6 years.
  • The Latest Trading Price of Panacea Biotec Ltd is ₹ 452.05 as of 26 Dec 15:30 .

Historical Market Cap of Panacea Biotec Ltd

No data available

* All values are in crore

Company Fundamentals for Panacea Biotec Ltd

No data available

Image

Panacea Biotec Ltd

NSE: PANACEABIO

Share Price

₹ 452.05

17.50 (4.03%)

stock direction

Last updated on: Dec 26, 2024

Market Price of Panacea Biotec Ltd

1M

1Y

3Y

5Y

Monitoring Panacea Biotec Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 2024452.05
24 Dec 2024434.55
23 Dec 2024429.35
20 Dec 2024448.4
19 Dec 2024458.9
18 Dec 2024452.8
17 Dec 2024462.2
16 Dec 2024486.5
13 Dec 2024465.65
12 Dec 2024465.15

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Panacea Biotec Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Panacea Biotec Ltd

No data available

No data available

Historical P/E Ratio of Panacea Biotec Ltd

No data available

* All values are in %

Historical Revenue of Panacea Biotec Ltd

No data available

* All values are in crore

Historical EBITDA of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Net Profit of Panacea Biotec Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Panacea Biotec Ltd News Hub

News

Panacea Biotec hits the roof on bagging order worth Rs 127-cr from UNICEF

The company will supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa ...

Read more

26 Dec 2024 10:30

News

Panacea Biotec wins order of Rs 127 cr from UNICEF

Panacea Biotec has received a Letter of Award from UNICEF for supply of 115 million doses ...

Read more

24 Dec 2024 17:54

News

Panacea Biotec to hold board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 13 November...

Read more

31 Oct 2024 12:09

News

Panacea Biotec to hold AGM

Panacea Biotec announced that the Annual General Meeting (AGM) of the company will be held...

Read more

18 Sep 2024 16:48

News

Panacea Biotec announces board meeting date

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

07 Aug 2024 10:25

News

Panacea Biotec to convene board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 30 May 2024...

Read more

13 May 2024 16:31

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Panacea Biotec Ltd Market Cap

What is the market cap of Panacea Biotec Ltd?

As of December 26, 2024, Panacea Biotec Ltd has a market capitalization of ₹2768.84, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Panacea Biotec Ltd's market capitalization?

Panacea Biotec Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Panacea Biotec Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Panacea Biotec Ltd's market capitalization change?

Panacea Biotec Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions